Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176137 | SCV000227744 | uncertain significance | not provided | 2014-11-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415760 | SCV002724549 | uncertain significance | Cardiovascular phenotype | 2020-01-03 | criteria provided, single submitter | clinical testing | The p.S7006L variant (also known as c.21017C>T), located in coding exon 84 of the TTN gene, results from a C to T substitution at nucleotide position 21017. The serine at codon 7006 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV000176137 | SCV005413097 | uncertain significance | not provided | 2024-05-17 | criteria provided, single submitter | clinical testing | PM2 |